Your Article Summary
Merck Shareholders Approve Merger With Schering-Plough
Merck & Co., 08/10/09
Merck and Co. announced that its shareholders voted overwhelmingly to approve the proposed merger with Schering–Plough. The preliminary tabulation indicates that more than 99% of shares voted were in favor of the transaction. Merck held its special shareholder meeting in Bridgewater, New Jersey to vote on the proposed merger.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Conference Call to Discuss Clinical Data Reported at Recent Medical Meetings
ImmunoGen, Inc., 12/04/09
Allos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematology Annual Meeting
Allos Therapeutics, 12/04/09
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 to be Presented at the 32nd Annual San Antonio Breast Cancer Symposium
Cytokinetics, 12/04/09
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Bayer CropScience and FuturaGene sign license agreement for drought tolerance technology in cotton
BayNews International, 12/04/09
Sanofi-aventis enters into an Exclusive Global Licensing Agreement with The Rockefeller University
Sanofi-aventis, 12/04/09
Watson Receives FTC Clearance for Arrow Acquisition
Watson Pharmaceuticals, 12/03/09
Article Search
Sponsor


See Latest Articles


